SOLANA BEACH, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that Gregory D. Gorgas, President and Chief Executive Officer of Artelo, will be a featured guest on the Benzinga All Access show.
Mr. Gorgas is scheduled to appear on Tuesday, April 23, 2024, at approximately 10:50 a.m. Eastern Time.
The event will be broadcast live and can be viewed at https://youtube.com/live/ZOUr1RBYCRE?feature=share. An archived recording of the presentation will be available on the investor relations section of the Company's website at https://ir.artelobio.com/news-events/ir-calendar.
About Benzinga All Access
Benzinga All Access is a first-of-its-kind show: part interview, part investor presentation. On All Access, Benzinga partners with companies to bring you in-depth one-on-one conversations with executives across a wide range of industries and asset classes. From emerging biotechs, to alternative real estate investment platforms, to everything in ...